Pharmaceutical News

RSS

Study finds PCV7 vaccine reduces bacterial pneumonia infection in children

The number of children admitted to English hospitals with bacterial pneumonia decreased by a fifth in the two years following the introduction of a vaccine to combat the disease, according to a new study published today in the journal Thorax.

27 Aug 2010

NICE suggests bortezomib, thalidomide for multiple myeloma patients

The National Institute for Health and Clinical Excellence (NICE) has released draft guidance which recommends the drugs bortezomib and thalidomide as first-line therapies for some patients with multiple myeloma, a type of cancer that affects cells in the bone marrow.

27 Aug 2010

Aethlon Medical receives approval for Chronic HCV Infection treatment

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that the Medanta Independent Ethics Committee (MIEC) at Medanta, The Medicity Institute (Medicity) has approved a treatment program entitled "Use of the Aethlon Hemopurifier in Treating Chronic HCV Infection in Combination with Standard of Care (SOC) Drug Therapy."

26 Aug 2010

Amneal Pharmaceuticals receives FDA approval for Spironolactone HCl tablets

Amneal Pharmaceuticals, LLC is pleased to announce that it has received U.S. FDA approval to manufacture Spironolactone HCl tablets in 25 mg, 50 mg and 100 mg strengths effective July 2, 2010.

26 Aug 2010

Seven year Aspirin for cancer trial

A large clinical trial looking at the cancer preventive actions of aspirin is underway. The seven year study will include six regional centers from Victoria including Ballarat, Bendigo, Geelong, Warrnambool, Traralgon and Shepparton. The ASPirin for Reducing Events in the Elderly (ASPREE) study will involve about 19,000 participants from Australia and the United States.

26 Aug 2010

AARP Report finds increase in brand-name drug costs outstrips inflation

"Retail prices for some of the most widely used brand-name prescription drugs shot up more than 8 percent in 2009, even as inflation plummeted to a record low, according to a new AARP analysis of retail drug price trends released today.

26 Aug 2010

BioTrends Research Group report provides in-depth view of kidney transplantation market

BioTrends Research Group, Inc. recently published its TreatmentTrends: Kidney Transplantation report. This report is based on online survey results from over 150 physicians (general nephrologists, transplant nephrologists and transplant surgeons). It provides an in-depth view of the kidney transplantation market, including the roles of the various specialties, promotional efforts and sales representative messaging, barriers to kidney transplant, the care of post-transplant patients, and current and projected use of immunosuppressive agents for induction, maintenance and acute rejection.

26 Aug 2010

Xcellerex, SK Chemicals sign memorandum of understanding to expand vaccine business in Korea

Xcellerex, Inc. announced today that it has signed a memorandum of understanding with SK Chemicals, Co., Ltd., one of South Korea's largest industrial groups, for an alliance to develop and commercialize SK-developed vaccines with Xcellerex's FlexFactory biomanufacturing platform. The companies expect to define specific terms of the alliance in the coming months.

26 Aug 2010

Sermo report highlights physician opinions about investigational oral antiplatelet treatment for ACS

Sermo, the world's largest online community for physicians, today announced a free Sermo Report titled, "FDA Committee Recommends Approval for Ticagrelor." The report covers physician opinions about the introduction of an investigational oral antiplatelet treatment for acute coronary syndrome.

26 Aug 2010

FDA accepts Sanofi Pasteur's Menactra vaccine sBLA for active immunization of infants and toddlers

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for use of Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for active immunization of infants and toddlers for the prevention of invasive meningococcal disease caused by serogroups A, C, Y, and W-135.

26 Aug 2010

Momenta Pharmaceuticals provides update on generic Lovenox litigation

Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that on August 25, 2010, the United States District Court for the District of Columbia denied sanofi-aventis U.S. LLC's request for a preliminary injunction directing the FDA to suspend and withdraw its approval of the Abbreviated New Drug Application (ANDA) filed by the Company's collaboration partner, Sandoz, for enoxaparin sodium injection USP, a generic version of Lovenox®. The decision is subject to appeal.

26 Aug 2010

Affordable Care Act that mandates free preventative services goes into effect in September

Starting in September, President Obama's Affordable Care Act will go into effect. The act mandates free preventative services such as cholesterol or breast cancer screenings and tetanus shots. But the question is, will doctors and patients take advantage of these new preventative services? "Unfortunately, thanks to our American healthcare system, we have been programmed to focus on treatment and not prevention," said Dr. David Samadi, a urologic oncologist specializing in prostate cancer treatment and robotic surgery, who is also the Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center in New York City.

26 Aug 2010

FDA approves Chelsea Therapeutics' Phase II protocol for CH-4051 antifolate in rheumatoid arthritis

Chelsea Therapeutics International, Ltd. announced confirmation by the U.S. Food and Drug Administration (FDA) that its proposed Phase II protocol for CH-4051 in rheumatoid arthritis has been approved by the agency.

26 Aug 2010

FDA notification confirms acyclovir Lauriad for oro-facial herpes labialis

BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, today announces that the US Food and Drug Administration (FDA) considers the positive results of the pivotal phase III study with acyclovir Lauriad acceptable to submit a 505(b)(2) New Drug Application of the product in the United States.

26 Aug 2010

Giant Eagle installs RxSafe 1800 pharmacy workflow automation system

RxSafe, LLC, the leader in automated high density robotic storage and retrieval systems for pharmacies, has recently installed an RxSafe 1800™ system at a Pittsburgh, Pennsylvania area supermarket for Giant Eagle, Inc., a leading regional multi-format food retailer.

26 Aug 2010

PCMA reports increase in retail prices of popular brand-name drugs

The Pharmaceutical Care Management Association (PCMA) issued the following statement on a new AARP report that examined retail prices of brand-name drugs and found that the 217 products most used by seniors increased by an average of 8.3 percent during 2009, while over the last five years retail prices for the most popular brand-name drugs increased 41.5 percent:

26 Aug 2010

Transparency needed in administration of drug benefits by pharmacy benefit managers

According to a new AARP report, the average retail price of the most popular brand-name drugs increased by 8.3 percent in 2009 and by 41.5 percent over the past five years – rates well in excess of inflation as measured by the Consumer Price Index. At the same time, major pharmacy benefit managers (PBMs) like CVS Caremark, Express Scripts, Inc. and Medco Health Solutions, Inc., hired by employers and other health plan sponsors to negotiate lower prices from drug manufacturers, experienced record profits, in some cases increasing five-fold over the past decade.

26 Aug 2010

Henry Ford Health System introduces 'Pill Timer' for medication management

A leader in healthcare, Henry Ford Health System will introduce at its hospitals and pharmacies "The Pill Timer," representing a "breakthrough" designed to improve treatment outcomes and reduce adverse drug events often resulting in costly hospital admissions due to poor medication management by patients.

26 Aug 2010

Treating metastatic melanoma tumors with specific genetic signature shows promising results

Use of an experimental targeted drug to treat metastatic melanoma tumors with a specific genetic signature was successful in more than 80 percent of patients in a phase 1 clinical trial.

26 Aug 2010

Prescription drug abuse soars despite state monitoring programs

Stateline: Over the past 10 years, "prescription drug abuse has soared to new levels. A recent White House study found a 400 percent increase in abuse from 1998 to 2008.

26 Aug 2010

Pharmaceutical News

Study finds PCV7 vaccine reduces bacterial pneumonia infection in children

NICE suggests bortezomib, thalidomide for multiple myeloma patients

Aethlon Medical receives approval for Chronic HCV Infection treatment

Amneal Pharmaceuticals receives FDA approval for Spironolactone HCl tablets

Seven year Aspirin for cancer trial

AARP Report finds increase in brand-name drug costs outstrips inflation

BioTrends Research Group report provides in-depth view of kidney transplantation market

Xcellerex, SK Chemicals sign memorandum of understanding to expand vaccine business in Korea

Sermo report highlights physician opinions about investigational oral antiplatelet treatment for ACS

FDA accepts Sanofi Pasteur's Menactra vaccine sBLA for active immunization of infants and toddlers

Momenta Pharmaceuticals provides update on generic Lovenox litigation

Affordable Care Act that mandates free preventative services goes into effect in September

FDA approves Chelsea Therapeutics' Phase II protocol for CH-4051 antifolate in rheumatoid arthritis

FDA notification confirms acyclovir Lauriad for oro-facial herpes labialis

Giant Eagle installs RxSafe 1800 pharmacy workflow automation system

PCMA reports increase in retail prices of popular brand-name drugs

Transparency needed in administration of drug benefits by pharmacy benefit managers

Henry Ford Health System introduces 'Pill Timer' for medication management

Treating metastatic melanoma tumors with specific genetic signature shows promising results

Prescription drug abuse soars despite state monitoring programs

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News